Humana (NYSE:HUM) Hits New 52-Week High – Here’s What Happened

Shares of Humana Inc. (NYSE:HUM) reached a new 52-week high on Wednesday . The company traded as high as $315.50 and last traded at $312.4950, with a volume of 6460 shares changing hands. The stock had previously closed at $310.55.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on HUM shares. Wolfe Research decreased their price target on shares of Humana from $325.00 to $250.00 and set an “outperform” rating on the stock in a research note on Monday, April 6th. Weiss Ratings restated a “sell (d+)” rating on shares of Humana in a report on Tuesday, April 21st. TD Cowen increased their price target on shares of Humana from $173.00 to $211.00 and gave the company a “hold” rating in a report on Friday, May 1st. Piper Sandler reissued a “neutral” rating and set a $254.00 price objective (up from $182.00) on shares of Humana in a research note on Wednesday, May 13th. Finally, Jefferies Financial Group raised their price objective on Humana from $235.00 to $290.00 in a research note on Thursday, April 30th. Eight research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $260.83.

Humana Trading Up 0.6%

The company has a market capitalization of $37.52 billion, a P/E ratio of 33.44, a PEG ratio of 2.84 and a beta of 0.68. The company’s fifty day simple moving average is $210.28 and its 200-day simple moving average is $226.76. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The business had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. During the same quarter last year, the firm earned $11.58 EPS. The business’s revenue for the quarter was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. Research analysts predict that Humana Inc. will post 9 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.1%. Humana’s dividend payout ratio (DPR) is presently 37.86%.

Insiders Place Their Bets

In other Humana news, insider Sanjay K. Shetty purchased 810 shares of the business’s stock in a transaction that occurred on Monday, February 23rd. The stock was purchased at an average price of $185.21 per share, for a total transaction of $150,020.10. Following the purchase, the insider directly owned 11,657 shares in the company, valued at approximately $2,158,992.97. This trade represents a 7.47% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.20% of the company’s stock.

Hedge Funds Weigh In On Humana

Several hedge funds and other institutional investors have recently made changes to their positions in HUM. Vanguard Group Inc. lifted its stake in shares of Humana by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock worth $3,652,890,000 after buying an additional 106,030 shares in the last quarter. Capital International Investors grew its position in shares of Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after purchasing an additional 3,097,571 shares in the last quarter. Pzena Investment Management LLC lifted its position in Humana by 34.3% during the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after buying an additional 1,398,774 shares in the last quarter. State Street Corp boosted its stake in Humana by 1.8% during the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock worth $1,403,877,000 after buying an additional 97,211 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA grew its holdings in Humana by 28.9% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after buying an additional 1,008,514 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.